← Back to Search

Behavioural Intervention

office-based vergence/accommodative therapy for Convergence Insufficiency

N/A

Waitlist Available

Research Sponsored by Salus University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 12 weeks of therapy

Awards & highlights

Study Summary

This trial will look at whether a specific type of therapy can improve symptoms of convergence insufficiency, a condition where the eyes have trouble working together when looking at nearby objects.

Eligible Conditions

Convergence Insufficiency

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 12 weeks of therapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 12 weeks of therapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 12 weeks of therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in average peak velocity for 4° symmetrical convergence steps after 12 weeks of therapy

Secondary outcome measures

Change in accuracy for 4° symmetrical convergence steps after 12 weeks of therapy

Change in latency for 4° symmetrical convergence steps after 12 weeks of therapy

Change in settling time for 4° symmetrical convergence steps after 12 weeks of therapy

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Vision therapy groupExperimental Treatment1 Intervention

Twelve, 60-minute, weekly visits of office-based vergence/accommodation therapy will be administered by a trained therapist combined with procedures to practice at home (15 minutes, 5 times per week). This treatment sequence is a well-accepted approach for treatment of CI and has been successfully implemented in previous studies. Fifteen minutes of home-based therapy was prescribed to be performed 5 days per week, and compliance with home-based therapy was monitored at each visit by the therapist

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Salus UniversityLead Sponsor

14 Previous Clinical Trials

917 Total Patients Enrolled

3 Trials studying Convergence Insufficiency

461 Patients Enrolled for Convergence Insufficiency

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I enroll myself in this scientific experiment?

"This clinical study is looking for around 60 participants that have opsoclonus and are aged between 9 to 17 years old."

Answered by AI

Can patients still sign-up for this research project?

"According to the clinicaltrials.gov website, this trial is still looking for volunteers. The listing was created on September 2nd, 2018 and was last updated on October 22nd, 2020."

Answered by AI

Does this research include elderly participants over the age of 75?

"According to the inclusion criteria set out by the researchers, applicants who are 9 to 17 years old can qualify for this trial. There are a total of 7 studies currently being conducted with participants under 18 and 3 with patients over 65."

Answered by AI

How many people will be participating in this trial?

"That is correct, the listing on clinicaltrials.gov does show that this particular trial is still looking for participants. This specific study was first made public on September 2nd, 2018 and has had one edit since then on October 22th, 2020. They are currently seeking 60 individuals to take part in the trial at 1 location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children

Mitchell Scheiman 2018. "Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03248336.